Gerald Neidigh
Optometrist · Richmond, VANPI 1841370012
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (56.2%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Alcon accounts for 67.9% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2023 at $4,981 and has fallen 77.9% since, to $1,100 in 2025. Among optometrist clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 153 payments — averaging $95.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$10K
- Johnson & Johnson Vision Care, Inc.$1K
- AbbVie$508
- Bausch & Lomb Americas Inc.$307
- ABB Con-cise Optical Group LLC$234
- Johnson & Johnson Surgical Vision, Inc.$226
- plus $2K from 23 others
What the payments were for
- Consulting fees$2602%
- Speaking & faculty fees$8,22556%
- Food & beverage$6,12342%
- Gifts$190%
- Entertainment$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 44 | $9,939 |
| Johnson & Johnson Vision Care, Inc. | 22 | $1,104 |
| AbbVie(2 entities) | 13 | $508 |
| Bausch & Lomb Americas Inc. | 8 | $307 |
| ABB Con-cise Optical Group LLC | 5 | $234 |
| Johnson & Johnson Surgical Vision, Inc. | 4 | $226 |
| Novartis | 9 | $225 |
| Carl Zeiss Meditec USA, Inc. | 3 | $206 |
| Sun Pharmaceutical Industries Inc. | 5 | $191 |
| Topcon Healthcare, Inc. | 2 | $176 |
| Coopervision Inc. | 4 | $171 |
| Lumibird Medical Inc. | 1 | $152 |
| Biotissue Holdings Inc. | 2 | $151 |
| Amgen | 1 | $122 |
| Carl Zeiss Meditec, Inc. | 2 | $118 |
| LKC Technologies, Inc. | 1 | $110 |
| Oyster Point Pharma, Inc. | 4 | $104 |
| Maculogix, Inc. | 3 | $97 |
| Sight Sciences, Inc. | 2 | $78 |
| Kala Pharmaceuticals, Inc. | 2 | $70 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $70 |
| Optos, Inc. | 3 | $61 |
| Harrow Eye, LLC | 3 | $58 |
| Tarsus Pharmaceuticals, Inc. | 2 | $46 |
| Eyevance Pharmaceuticals LLC | 1 | $30 |
| Mallinckrodt Hospital Products Inc. | 1 | $29 |
| Lombart Brothers, Inc. | 1 | $24 |
| Thea Pharma Inc. | 1 | $20 |
| Carl Zeiss Meditec AG | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Precision 1$6,250
- DAILIES TOTAL1$6,206
- Air Optix Color$4,400
- DAILIES$2,115
- AIR OPTIX$1,815
- AIR OPTIX for Astigmatism$1,700
- Dailies Aqua Comfort Plus$1,700
- Acuvue$503
- TOTAL30$488
- Prokera$129
- INFUSE$125
- TEPEZZA$122
- Clear Care$115
- MARLO$114
- CLARUS$112
- LUMIGAN$109
How this compares
$14,647 in reported general payments places this provider in the 95th percentile of 1,230 optometrist providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 22 | $26,452 |
| Latanoprost | 35 | $234 |
| Timolol Maleate | 15 | $94 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis | $508 | $26,45222 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,230 optometrist providers in Virginia.
Other optometrist in Richmond
- Jacqueline TheisRichmond$80K
- Joseph AllenRichmond$75K
- Jeffrey FardinkRichmond$23K
- Raquel MoncrieffeRichmond$18K
- Eric NilsenRichmond$11K
- Kristine Hue vanRichmond$8K
- Charline AnselmeRichmond$6K
- Walter WhitleyNorfolk$546K
- Keith SmithsonReston$74K
- Michael SwattsChesapeake$59K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.